Stage iiic breast cancer has been the subject of sustained clinical investigation across multiple research sites.

12 total trials for this combination

Showing top 10 of 12 trials

Trials

NCT ID	Title	Status	Phase
NCT01276496	Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery	COMPLETED	PHASE1
NCT02002533	Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy	COMPLETED	NA
NCT02646319	Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations	COMPLETED	EARLY_PHASE1
NCT01606241	Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	COMPLETED	PHASE1
NCT01776008	Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer	TERMINATED	PHASE2
NCT02445391	Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy	ACTIVE_NOT_RECRUITING	PHASE3
NCT02488967	Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer	ACTIVE_NOT_RECRUITING	PHASE3
NCT03971409	Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer	ACTIVE_NOT_RECRUITING	—
NCT01953588	Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery	ACTIVE_NOT_RECRUITING	PHASE3
NCT02860000	Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer	COMPLETED	PHASE2

Related Pages

All Stage iiic breast cancer trials All trials in Rochester, United States